Editor's Note A Coherent Market Insights report predicts the global market for spinal fusion devices is set to grow at a 4.6% compound annual growth rate through 2025, after hitting $7.5 billion in 2016, according to the April 17 Becker’s Spine Review. The increasing incidence of spinal deformities will boost…

Read More

Editor's Note In this study, a significant mismatch was found between parents’ and pediatric surgeons’ expectations on the role of the surgeon on the day of surgery, with parents expecting more direct involvement by the attending surgeon. A total of 110 parents and 84 pediatric surgeons and surgical residents completed…

Read More

Editor's Note The Joint Commission on April 17 announced that it had issued a new Sentinel Event Alert 59: Physical and verbal violence against healthcare workers. The Joint Commission issued the alert during Workplace Violence Awareness Month to help healthcare workers in hospitals and other healthcare settings recognize violence from…

Read More

Editor's Note The Food and Drug Administration (FDA) on April 17 announced that it had approved a firmware update that is now available for certain Abbott (formerly St Jude Medical) implantable cardiac devices (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds). The update is a corrective action (recall) to reduce the…

Read More

Editor's Note Daily narcotic use before adult spinal deformity (ASD) surgery was associated with poorer outcomes 2 years postoperatively, this study finds. In this multicenter analysis of 575 patients, 425 had complete 2-year follow-up. A total of 44% reported daily preoperative narcotic use. Compared with non-daily users, daily narcotic users…

Read More

Editor's Note The Food and Drug Administration (FDA) on April 13 announced the recall by Coastal Meds (Biloxi, Mississippi) of all nonexpired products marketed as sterile because of visible particles in some of the drug vials for injection and poor sterile production practices. The FDA on April 5 requested the…

Read More

Editor's Note No difference was found in the effect of perioperative ß-blockade (metoprolol continuous release 200 mg for 30 days) versus placebo on postoperative outcomes between older and younger patients in this study (POISE [perioperative ischemia evaluation] trial). In this analysis of 8,351 patients from 190 centers in 23 countries,…

Read More

Editor's Note The Food and Drug Administration (FDA) on April 12 announced the recall by Premier Pharmacy Labs (Weeki Wachee, Florida) of certain lots of sterile injectable products because of a potential lack of sterility assurance. The products include morphine sulfate (2 mg/mL and 3 mg/mL), hydromorphone HCL 1 mg/mL,…

Read More

Editor's Note Video observation was not be as effective as evaluating live performance in promoting OR teamwork in this study. A total of 1,410 briefs were analyzed−325 live observations and 1,085 videos−and 1,398 debriefs were evaluated−166 live and 1,232 video. For briefs, there was greater compliance with live observation than…

Read More

Editor's Note The Joint Commission on April 11 released the top 5 requirements identified most frequently as “not compliant” during surveys and reviews that took place from January 1 to December 31, 2017. New to the table is data on Perinatal Care Certification. The top 5 for Hospital Accreditation are:…

Read More